TET Protein

TFMB-(S)-2-HG is a potent inhibitor of TET2 and EglN prolyl hydroxylases. It downregulates Wnt3a and intranuclear β-catenin protein expression, and inhibits osteogenic differentiation of cells. TFMB-(S)-2-HG shows potential for research in acute myeloid leukemia (AML).

Bobcat339 hydrochloride is a potent and selective cytosine-based inhibitor of TET (ten-eleven translocation) enzymes, with IC₅₀ values of 33 μM for TET1 and 73 μM for TET2. By inhibiting TET-mediated DNA demethylation, it modulates epigenetic regulation and gene transcription. Bobcat339 hydrochloride is a valuable tool in epigenetics research and serves as a potential lead compound for developing therapeutics targeting DNA methylation-related diseases.

UC-514321 is a potent inhibitor of STAT3 and STAT5, effectively repressing TET1 expression without affecting TET2 or TET3. This compound demonstrates significant promise for the treatment of acute myeloid leukemia (AML) in both in vitro and in vivo settings. Its selective action and low toxicity profile make it a valuable tool for research in cancer therapeutics.

NSC-370284 is a selective inhibitor of ten-eleven translocation 1 (TET1), targeting the enzymatic conversion of cytosine to 5-hydroxymethylcytosine (5hmC). This compound effectively reduces TET1 expression levels by interacting with STAT3/5 signaling pathways. NSC-370284 is valuable for research in epigenetics and may be utilized to explore the role of TET1 in various biological processes and disease states.

Bobcat339 is a selective inhibitor of the TET enzymes, exhibiting IC50 values of 33 μM and 73 μM for TET1 and TET2, respectively. This compound is significant for studies in epigenetics, including the modulation of DNA methylation and gene expression. Bobcat339 serves as a valuable tool for researchers exploring the therapeutic potential of targeting TET enzymes in various biological contexts.

TETi76 is a potent inhibitor of TET family enzymes, demonstrating IC50 values of 1.5 μM for TET1, 9.4 μM for TET2, and 8.8 μM for TET3. By competitively binding to the active site of these enzymes, TETi76 effectively decreases cytosine hydroxymethylation and inhibits the clonal growth of TET2 mutant cells both in vitro and in vivo, while sparing normal hematopoietic precursor cells. This selective activity makes TETi76 a valuable tool for investigating leukemia and studying TET-related pathways in cancer research.

NSC-311068 is a potent inhibitor of TET1, targeting the enzyme's transcriptional activity and its role in modifying 5-hydroxymethylcytosine (5hmC). This compound effectively reduces TET1 expression levels and attenuates global 5hmC levels. NSC-311068 demonstrates significant cytotoxicity in acute myeloid leukemia (AML) cells characterized by elevated TET1 expression, making it a valuable tool for studying TET1-related pathways and potential therapeutic approaches in AML.

Tet1-Cys peptide is a specifically designed peptide that targets the GT1b ligand. It demonstrates the ability to bind to the neuronal ganglioside receptor GT1b, facilitating neuronal targeting in research applications. The inclusion of a cysteine residue in the Tet1-Cys peptide allows for efficient drug conjugation, making it a valuable tool for studies focused on drug delivery mechanisms and neuronal interactions.

Tet1 peptide (HLNILSTLWKYR) is a neuron-specific ligand that selectively targets GT1B gangliosides. This peptide plays a crucial role in studies related to neuronal function and cell signaling. A commonly used variant includes a cysteine residue at the C-terminus (HLNILSTLWKYRC), facilitating peptide conjugation for drug delivery studies and enhancing research applications in neurobiology.

Succinic acid sodium functions as an effective anxiolytic agent. It has demonstrated inhibitory effects on colonic epithelial cell proliferation in vivo and can down-regulate the expression of key genes such as KCNMB1 and TET1. This compound is particularly useful for research involving gestational hypertension and related physiological studies.

5-Hydroxymethylcytosine (5hmC) is an oxidized derivative of 5-methylcytosine found within mammalian DNA. Generated through an enzymatic process involving the Ten-eleven translocation (TET) enzymes TET1, TET2, and TET3, 5hmC serves as an important marker for investigating the dynamic processes of DNA demethylation and gene transcription. Its presence is particularly significant in the study of conditions such as non-small cell lung cancer, neurodegenerative diseases like Alzheimer’s and Parkinson’s, and various hematological malignancies, including acute myeloid leukemia and myelodysplastic syndromes.